Simultaneous deletion of PAX5 and CDKN2A is a common event in leukemogenesis and most ALL patients with a deletion of PAX5 have a concurrent deletion of CDKN2A (Kimet al., 2009). Here, CDKN2A is linked to acute lymphoblastic leukemia.